These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 32894848)
1. Noninvasive Detection of Hemolysis with ETCOc Measurement in Neonates at Risk for Significant Hyperbilirubinemia. Bhatia A; Chua MC; Dela Puerta R; Rajadurai VS Neonatology; 2020; 117(5):612-618. PubMed ID: 32894848 [TBL] [Abstract][Full Text] [Related]
2. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Kaplan M; Herschel M; Hammerman C; Hoyer JD; Stevenson DK Pediatrics; 2004 Aug; 114(2):e213-9. PubMed ID: 15286259 [TBL] [Abstract][Full Text] [Related]
3. Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates. Kaplan M; Herschel M; Hammerman C; Karrison T; Hoyer JD; Stevenson DK Clin Chim Acta; 2006 Mar; 365(1-2):177-82. PubMed ID: 16188248 [TBL] [Abstract][Full Text] [Related]
4. An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns. Bao Y; Zhu J; Ma L; Zhang H; Sun L; Xu C; Wu J; He Y; Du L J Pediatr; 2022 Nov; 250():16-21.e3. PubMed ID: 35835229 [TBL] [Abstract][Full Text] [Related]
5. Prediction of hyperbilirubinemia in near-term and term infants. Stevenson DK; Fanaroff AA; Maisels MJ; Young BW; Wong RJ; Vreman HJ; MacMahon JR; Yeung CY; Seidman DS; Gale R; Oh W; Bhutani VK; Johnson LH; Kaplan M; Hammerman C; Nakamura H J Perinatol; 2001 Dec; 21 Suppl 1():S63-72; discussion S83-7. PubMed ID: 11803421 [TBL] [Abstract][Full Text] [Related]
6. Prediction of hyperbilirubinemia in near-term and term infants. Stevenson DK; Fanaroff AA; Maisels MJ; Young BW; Wong RJ; Vreman HJ; MacMahon JR; Yeung CY; Seidman DS; Gale R; Oh W; Bhutani VK; Johnson LH; Kaplan M; Hammerman C; Nakamura H Pediatrics; 2001 Jul; 108(1):31-9. PubMed ID: 11433051 [TBL] [Abstract][Full Text] [Related]
7. Higher ETCOc predicts longer phototherapy treatment in neonatal hyperbilirubinemia. Zhan YL; Peng HB; Jin ZC; Su JF; Tan XY; Zhao L; Zhang L Front Pediatr; 2023; 11():1154350. PubMed ID: 37114002 [TBL] [Abstract][Full Text] [Related]
8. Corrected end-tidal carbon monoxide closely correlates with the corrected reticulocyte count in coombs' test-positive term neonates. Javier MC; Krauss A; Nesin M Pediatrics; 2003 Dec; 112(6 Pt 1):1333-7. PubMed ID: 14654606 [TBL] [Abstract][Full Text] [Related]
9. Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis. Christensen RD; Malleske DT; Lambert DK; Baer VL; Prchal JT; Denson LE; Gerday E; Weaver Lewis KA; Shepherd JG Neonatology; 2016; 109(1):1-5. PubMed ID: 26394287 [TBL] [Abstract][Full Text] [Related]
10. End-tidal carbon monoxide is predictive for neonatal non-hemolytic hyperbilirubinemia. Okuyama H; Yonetani M; Uetani Y; Nakamura H Pediatr Int; 2001 Aug; 43(4):329-33. PubMed ID: 11472573 [TBL] [Abstract][Full Text] [Related]
11. End-tidal carbon monoxide concentrations measured within 48 hours of birth predict hemolytic hyperbilirubinemia. Cheng X; Lin B; Yang Y; Yu Y; Fu Y; Yang C J Perinatol; 2024 Jun; 44(6):897-901. PubMed ID: 38627593 [TBL] [Abstract][Full Text] [Related]
12. Comparison of end-tidal carbon monoxide measurements with direct antiglobulin tests in the management of neonatal hyperbilirubinemia. Elsaie AL; Taleb M; Nicosia A; Zangaladze A; Pease ME; Newton K; Schutzman DL J Perinatol; 2020 Oct; 40(10):1513-1517. PubMed ID: 32203175 [TBL] [Abstract][Full Text] [Related]
13. Identification of risk for neonatal haemolysis. Bhutani VK; Maisels MJ; Schutzman DL; Castillo Cuadrado ME; Aby JL; Bogen DL; Christensen RD; Watchko JF; Wong RJ; Stevenson DK Acta Paediatr; 2018 Aug; 107(8):1350-1356. PubMed ID: 29532503 [TBL] [Abstract][Full Text] [Related]
14. Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia. Bhutani VK; Srinivas S; Castillo Cuadrado ME; Aby JL; Wong RJ; Stevenson DK Acta Paediatr; 2016 May; 105(5):e189-94. PubMed ID: 26802319 [TBL] [Abstract][Full Text] [Related]
15. Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production. Du L; Ma X; Shen X; Bao Y; Chen L; Bhutani VK Semin Perinatol; 2021 Feb; 45(1):151351. PubMed ID: 33308896 [TBL] [Abstract][Full Text] [Related]
19. Hemolysis and Glucose-6-Phosphate Dehydrogenase Deficiency-Related Neonatal Hyperbilirubinemia. Kaplan M; Wong RJ; Stevenson DK Neonatology; 2018; 114(3):223-225. PubMed ID: 29940590 [TBL] [Abstract][Full Text] [Related]
20. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]